Timely vaccination is the best way to protect your child from serious vaccine-preventable diseases. So book ahead, make an appointment with your doctor and save the date to vaccinate.
Download as PDF

Childhood vaccines

Age Disease Vaccine Information
Birth Hepatitis B H-B-Vax II or Engerix B (IM) Within 7 days of birth
(ideally within 24 hours)
6 weeks Diphtheria, tetanus, pertussis, Haemophilus influenzae type b, hepatitis B, polio Infanrix Hexa (IM)
Pneumococcal Prevenar 13 (IM)
Rotavirus Rotarix (Oral) Dose 1 limited to 6-14 weeks of age
Meningococcal B (Aboriginal1 children only) Bexsero (IM) Prophylactic paracetamol recommended. Catch up available for Aboriginal children <2 until 30 June 2023
4 months Diphtheria, tetanus, pertussis, Haemophilus influenzae type b, hepatitis B, polio Infanrix Hexa (IM)
Pneumococcal Prevenar 13 (IM)
Rotavirus Rotarix (Oral) Dose 2 limited to 10-24 weeks
Meningococcal B (Aboriginal children only) Bexsero (IM) Prophylactic paracetamol recommended. Catch up available for Aboriginal children <2 until 30 June 2023
6 months Diphtheria, tetanus, pertussis, Haemophilus influenzae type b, hepatitis B, polio Infanrix Hexa (IM) Children ≥6 months with at risk conditions for invasive pneumococcal disease are recommended to receive an additional dose of Prevenar 13 – see the Australian Immunisation Handbook.

Aboriginal children ≥6 months with certain at risk conditions may require an additional dose of Bexsero – see the Australian Immunisation Handbook.
12 months Meningococcal ACWY Nimenrix (IM)
Pneumococcal Prevenar 13 (IM)
Measles, mumps, rubella MMR II or Priorix (IM or SC)
Meningococcal B (Aboriginal children only) Bexsero (IM) Prophylactic paracetamol recommended. Catch up available for Aboriginal children <2 until 30 June 2023
18 months Diphtheria, tetanus, pertussis Infanrix or Tripacel (IM)
Measles, mumps, rubella, varicella Priorix Tetra or Proquad (IM or SC)
Haemophilus influenzae type b ACT-HIB (IM or SC)
4 years Diphtheria, tetanus, pertussis, polio Infanrix-IPV or Quadracel (IM) Children with at risk conditions for invasive pneumococcal disease are recommended to receive an additional dose of Pneumovax 23 – see the Australian Immunisation Handbook

At risk groups, adolescents and adults

Age/Condition Disease Vaccine Information
All people with asplenia, hyposplenia, complement deficiency and treatment with eculizumab Meningococcal ACWY Nimenrix (IM) See the Australian Immunisation Handbook for required doses and timing
Additional groups are recommended to receive these vaccines but these are not funded
Meningococcal B Bexsero (IM)
>5 years with asplenia or hyposplenia Haemophilus influenzae type b ACT-HIB (IM or SC) If incompletely vaccinated or not vaccinated in childhood
Year 7 Diphtheria, tetanus, pertussis Boostrix (IM)
Human papillomavirus Gardasil 9 (IM)
Year 10 Meningococcal ACWY Nimenrix (IM)
Pregnant Influenza Influenza Any trimester
Pertussis Boostrix or Adacel (IM) Each pregnancy between 20-32 weeks
Aboriginal people ≥50 years Pneumococcal Prevenar 13 (IM) then Pneumovax 23 (IM) Prevenar 13: ≥50 years
Pneumovax 23: 2-12 months later
Pneumovax 23: at least 5 years later
70 years Pneumococcal Prevenar 13 (IM) Pneumococcal funded for people ≥70
Zoster Zostavax (SC) Catch up available for 71-79 year olds until 31 October 2023
People with at risk conditions for invasive pneumococcal disease See the Australian Immunisation Handbook for conditions recommended to receive Prevenar 13 and Pneumovax 23

Influenza

Age/At risk condition Recommendation Information
All children 6 months <5 years Annual influenza vaccination Discuss influenza vaccination with other present family members. For vaccine brands and eligibility see Seasonal influenza vaccination.
Aboriginal people ≥6 months
People with at risk conditions ≥6 months
≥65 years
Pregnant women

Notes

  1. The term Aboriginal is inclusive of Aboriginal and Torres Strait Islander people.

Current as at: Thursday 30 March 2023
Contact page owner: Immunisation